Clinical Pharmacology & Pharmacotherapy, KU Leuven
@PharmaKULeuvenOur group focuses on the relationship between drugs and their safe and efficient use in humans https://t.co/FINLuMh4Q5
Similar User
@BrJPharmacol
@BritJClinPharm
@JCVPOnline
@PRandP_Journal
@FrontPharmacol
@GuidetoPHARM
@BPSAssessment
@UNC_PHCO
@ASPET
@PharmaVetmeduni
@ASCEPTanz
@PharmacologyCan
@BritPharmSoc
@Farmaceuticos_
@CPACLab
What matters to patients with #IBD in their treatment ? As a patient, complete the survey now! A survey in collaboration with @efcca, @ibdleuven and @PharmaKULeuven! …preferencesurvey.sawtoothsoftware.com/cgi-bin/ciwweb…
✅📢Call for papers! Regulatory Science: Addressing Uncertainties in Medicines Development, Evaluation and Use Edited by Rosanne Janssens @LieseBarbier (@PharmaKULeuven) & @carla_Mtorre ➡️Find out more & submit here fro.ntiers.in/Q3v8 #clinicaltrial #regulatoryevaluation
Karakter 83: AI + eiwitvorming (@noort_zuit) en + onderwijs (@anneliesraes85), wat te doen met gevangenissen (@Pieter_De_Witte), het denken van Bruno Latour (@MassSimons), de toxiciteit van de Style Congo (@LievenDeCauter), de stem van de patiënt (@LieseBarbier en team) en meer!
📢 PhD VACANCY ALERT #PhD position focusing on stakeholder perspectives on #gene #therapy in #cardiomyopathy More information and application here: (deadline 27/07!) kuleuven.be/personeel/jobs… #recruiting #phdchat @PascalBorry @eva_vst @LieseBarbier @dphpckuleuven
📢 Together with the @CBMER_KULeuven we are looking for an enthusiastic Dutch-speaking PhD researcher to investigate ethical and societal challenges of gene therapy in cardiomyopathy @PascalBorry @eva_vst @LieseBarbier Interested? Find out more here ⤵️:
New vacancy! We are looking for an enthusiastic Dutch-speaking-PhD student who will investigate the ethical and societal challenges of gene therapy in cardiomyopathy. Interested? Find out more here: ow.ly/zIPa50OFcnV #PhD #vacancy
New Special issue now open for article submission 📢 ▶️ Regulatory Science: How to address Uncertainties in Drug development, Evaluation, and Use Rosanne Janssens, @LieseBarbier , @carla_MTorre
✅📢Call for papers! Regulatory Science: Addressing Uncertainties in Medicines Development, Evaluation and Use Edited by Rosanne Janssens @LieseBarbier (@PharmaKULeuven) & @carla_Mtorre ➡️Find out more & submit here fro.ntiers.in/Q3v8 #clinicaltrial #regulatoryevaluation
Happy to share our latest publication in BMC Health Service Research, which advances recommendations that may facilitate development of a #regulatory framework on #electronicinformedconsent in clinical research. bmchealthservres.biomedcentral.com/articles/10.11… #decentralizedtrials #qualitativeresearch
An important day for #biosimilars! This EMA/HMA joint statement on biosimilar #interchangeability is a huge step forward in building trust in biosimilars and harmonizing the #regulatory message on biosimilars in the EU! #onevoice #EMA #NCAs #regulatoryconvergence
🆕 EU-approved 🇪🇺 #biosimilar #medicines are interchangeable with their reference medicine or an equivalent biosimilar 💊💉 Biosimilar medicines provide #patients with more therapeutic options to treat serious diseases such as #cancer and #diabetes. 👉 ema.europa.eu/en/news/biosim…
New Research: Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking frontiersin.org/articles/10.33… #pharmacology
New paper alert! Interested to learn more about the Belgian biosimilar landscape and concrete ways to improve #biosimilaruse and #switching? Read the full text here ⏩ frontiersin.org/articles/10.33… #biosimilars #policymaking #offpatentbiologicals #research #healthpolicy @MABELFund
New #KCE report on Compulsory licensing for #expensive medicines: #legal environment and #economic consequences #compulsorylicensing #expensivemedicines #KULeuven @PharmaKULeuven
Zijn dwanglicenties een oplossing voor dure geneesmiddelen? Een KCE rapport geeft een stand van zaken over deze vraag tinyurl.com/bdzza48t
❇️New PhD opportunity! Are you our new colleague? Our Unit is #hiring a #PhD researcher to investigate how #patientpreference research can be optimally conducted and integrated in healthcare decision making #kuleuven More information 👇: kuleuven.be/personeel/jobs…
Fresh from the press: Our @MayoClinic Proceedings Editorial on biosimilar implementation success factors that can help deliver benefits from #biosimilars to #US patients! Full text available here: authors.elsevier.com/c/1fAVE5qq8T-~… #MayoClinic @MABELFund @PharmaKULeuven
Barbier and colleagues have investigated how #regulators on pan-European and national level provide information and guidance to #stakeholders on #biosimilars and their use, with a focus on #interchangeability, #switching and #substitution. ow.ly/41s250IGTri
Interested in reading about our learnings on benefit-sharing programs? The full content is accessible via the link: link.springer.com/article/10.100… #BioDrugs #biosimilars #benefitsharing #gainsharing #bestvalue #qualityofcare #pharmaceuticals #policymaking #healthcare #mabelfund
Happy to share our latest paper in which we investigated how #regulators provide information and #guidance on #biosimilars and their use in Europe ❇️ Interested to learn about our findings? The full text can be accessed here frontiersin.org/articles/10.33… #interchangeability #switching
Barbier and colleagues have investigated how #regulators on pan-European and national level provide information and guidance to #stakeholders on #biosimilars and their use, with a focus on #interchangeability, #switching and #substitution. ow.ly/41s250IGTri
Issue 16 of @DrugsJournal now online with three articles on biosimilars bit.ly/3n25k7G including a great final summary on the topic by Liese Barbier and Arnold Vulto bit.ly/3qnJldt
Watch our recent departmental movie here: youtu.be/WsXAnAV5Gh0
New Research: Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care frontiersin.org/articles/10.33… #pharmacology
Een Leuvens team onderzocht wat patiënten weten over biosimilars. Blijkt 62% van de 657 ondervraagden niet te weten wat biosimilars zijn! Tssss... Betrek de patiënt bij zijn/haar zorg! reumanet.be/wat-weten-we-o…
United States Trends
- 1. Travis Hunter 12,9 B posts
- 2. Arkansas 27,6 B posts
- 3. Heisman 5.493 posts
- 4. Quinn 14,5 B posts
- 5. Cam Coleman N/A
- 6. Clemson 5.689 posts
- 7. Colorado 67,7 B posts
- 8. #HookEm 3.019 posts
- 9. Isaac Wilson N/A
- 10. Northwestern 6.690 posts
- 11. $CUTO 8.149 posts
- 12. Sark 1.886 posts
- 13. #NWSL N/A
- 14. Sheppard 2.959 posts
- 15. Tulane 2.553 posts
- 16. Carnell Tate 1.714 posts
- 17. Mercer 4.075 posts
- 18. Jeremiah Smith 1.430 posts
- 19. #SkoBuffs 3.773 posts
- 20. Caleb Downs N/A
Who to follow
-
British Journal of Pharmacology (BJP)
@BrJPharmacol -
British Journal of Clinical Pharmacology (BJCP)
@BritJClinPharm -
Journal of Cardiovascular Pharmacology
@JCVPOnline -
Pharmacology Research & Perspectives (PR&P)
@PRandP_Journal -
Frontiers - Pharmacology and Toxicology
@FrontPharmacol -
GuidetoPharmacology
@GuidetoPHARM -
BPS Assessment
@BPSAssessment -
UNC Pharmacology
@UNC_PHCO -
ASPET
@ASPET -
Institute of Pharmacology and Toxicology
@PharmaVetmeduni -
ASCEPT
@ASCEPTanz -
PharmacologyCanada
@PharmacologyCan -
British Pharmacological Society
@BritPharmSoc -
Consejo General Colegios Farmacéuticos
@Farmaceuticos_ -
Clinical Pharmacology & Analytical Chemistry Lab
@CPACLab
Something went wrong.
Something went wrong.